[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
UK industry says govt green target may raise costs
NOTE: I will be at the Health Physics Society Meeting and then out of the
country (Feb 15 - March 11). There will be no news distributions during
this time unless I find some good internet connections.
Index:
UK industry says govt green target may raise costs
Koizumi vague on planned U.S. subcritical nuclear test
Framatome ANP, Inc./Entergy Team Wins License Renewal at Cook Nuclear Plant
Novoste Receives FDA Approval for Smaller Beta-Cath System Catheter
SCT Awarded New Patent for CaF2 Technology
=======================================
UK industry says govt green target may raise costs
LONDON, Feb 14 (Reuters) - British industry on Thursday said greater use of
renewable energy like wind power, called for in a report to ministers, could push up
costs and make UK companies less competitive in world markets.
But environmentalists said the report's targets on green energy were not ambitious
enough.
"If the cost base to industry increases as a result of a shift towards green power
that will damange Britain's global competitiveness," said Ruth Lea, head of the
policy unit at the Institute of Directors (IOD).
"It is a worry that Britain, but not the U.S., will be taking on board environmental
costs," she told Reuters, highlighting the different approaches both governments
are taking in tackling global warming.
The root-and-branch review of Britain's long-term energy needs called for a near
tenfold increase by 2020 in the amount of electricity to be generated from
renewables to 20 percent of the energy mix.
The shift towards greener energy would form part of the UK's strategy to cut
greenhouse gas emissions, blamed by many scientists for contributing to global
warming.
The Confederation of British Industry (CBI) said it broadly welcomed the findings of
the energy review, but urged the government not to adopt policies which impose
damaging costs on business.
"The market is the best way to meet the sometimes conflicting needs of customers
and the environment," CBI Deputy Director-Genergy John Cridland said in a
statement.
U.S. LOOKS TO DIFFERENT ROUTE
In stark contrast to Britain, the United States on Thursday called for a gradual
reduction in greenhouse gas emissions setting goals and incentives for cuts based
on U.S. economic growth.
The U.S. plan to "slow, stop and then as science justifies, reverse" emissions sees
cutting so-called "greenhouse gas intensity" -- the ratio of emissions to U.S. gross
domestic product (GDP) growth -- by 18 percent over the next 10 years.
Britain aims to cut emissions by 23 percent in absolute terms by 2010 on 1990
levels.
The UK goal is in excess of targets agreed in Bonn last year as part of the 1997
Kyoto protocol. Washington pulled out of the pact last year saying its Kyoto target
of a five percent reduction would damage its economy.
The U.S. Department of Energy forecasts a 47 percent rise in greenhouse gases
from 1990-2020 assuming no regulatory changes.
Chris Hewett of the Institute for Public Policy Research think tank rejected the U.S.
stance.
"Britain has proved that you can cut emissions and still have a very healthy
economy. There is no inextricable link bewteen CO2 emissions and economic
growth."
But the IOD's Lea warned British consumers might end up paying the price.
"If it is the case renewables will be undercutting fossil fuels in years to come, that
will be great. But if the cost is higher it will be industry and the consumer who
pays," said Lea.
According to UK government reseach advances in green energy technology will
see the cost of wind power undercutting electricity from fossil-fuelled power
stations within 20 years.
The government-commissioned energy review also said the country should keep
an open mind about nuclear power and should not worry about having to rely on
imported natural gas.
Energy Minister Brian Wilson said the report stressed renewables and energy
efficiency, but also kept the option open of investing anew in nuclear and cleaner
coal.
MUTED GREEN ENTHUSIASM
Mark Johnston of Greenpeace called the review "timid," while Nick Goodall of the
British Wind Energy Association said, "this (20 percent by 2020) target is far too
modest - companies are already gearing up to generate this much from wind
energy alone."
By keeping the nuclear option open it was a "heavily disguised love letter from
number 10 (Prime Minister Blair's residence) to the nuclear industry," said
Johnston.
"The target on renewables has not been so much increased as extended," said the
green campaigner referring to the current target of 10 percent renewables by 2010.
At present only 2.8 percent of power is classed as renewable.
The PIU report also recommends strict reductions in emissions through efficiency
gains, setting a target of 40 percent savings over the next 18 years.
"We are pleased there is a clear recognition that energy efficiency is the most cost
effective way of delivering carbon cuts," he said.
The PIU also review said the risks of relying on imported gas can be managed
through enhanced diplomatic activity, highlighting the fact 70 percent of the world's
gas supplies can be accessed from Europe.
Worries about security of supply have increased as Britain edges towards
becoming a net importer of the fuel in the next coupleo of years. By 2020 the
country is set to be 70 percent dependent on imported gas which provides 40
percent of its electricity.
-------------------
Koizumi vague on planned U.S. subcritical nuclear test
TOKYO, Feb. 14 (Kyodo) - Prime Minister Junichiro Koizumi gave a nebulous
reaction Thursday to a subcritical nuclear test planned to be conducted soon in the
United States, only saying the issue should be regarded in the light of the
international move toward nuclear disarmament.
''I know there is an international understanding that the test is not interpreted as a
nuclear explosion,'' enabling it to clear the Comprehensive Test Ban Treaty,
Koizumi told reporters at his official residence.
The plan by the U.S. and Britain to jointly conduct a subcritical nuclear test at an
underground test site in Nevada on Thursday, local time, was announced by the
U.S. Energy Department.
Koizumi's comments followed a similarly vague reaction by top Japanese
government spokesman Yasuo Fukuda.
''Japan would never recommend such a test,'' Chief Cabinet Secretary Fukuda told
reporters, ''but we cannot say no to all such tests, either.''
''If such tests are banned, it's possible that any country could demand that the
world allows it to conduct a real test,'' Fukuda said.
There was anger from Hiroshima and Nagasaki, the two cities that were hit by U.S.
atomic bombs in 1945.
Sunao Tsuboi, a survivor of the bombing of Hiroshima and organizer of an
antinuclear movement, said, ''I'm worried that this test could encourage Israel and
North Korea, which are believed to be undeclared nuclear powers, as well as the
declared nuclear powers, to carry out similar tests.''
Nagasaki Gov. Genjiro Kaneko sent letters to U.S. and British embassies in Tokyo
urging the countries to stop subcritical nuclear tests, officials of the prefectural
government said.
He also sent a letter to Foreign Minister Yoriko Kawaguchi asking that Japan try to
dissuade the nuclear powers from holding the test.
Nagasaki Mayor Itcho Ito also denounced the test plan, saying ''It could refuel
concern over a new phase of competition for nuclear weapons development that
would not only tempt France and China to conduct tests but also could lead to the
destruction of the planet.''
------------------
Framatome ANP, Inc./Entergy Team Wins License Renewal at Cook Nuclear Plant
LYNCHBURG, Va. and JACKSON, Miss.--(BUSINESS WIRE)--Feb. 13, 2002--The
team of Framatome ANP, Inc. and Entergy has been awarded a contract to provide
license renewal management to American Electric Power Company's Cook
Nuclear Power Plant at Bridgman, MI - making the Framatome/Entergy team the
largest provider of license renewal services to the U.S. nuclear power industry.
The contract will be implemented over several years culminating in the preparation
and presentation of the license renewal documentation to the U.S. Nuclear
Regulatory Commission (NRC) for approval in November 2003.
This is the second contract for the Framatome/Entergy team outside of the five
Entergy plants. Previously a contract for license renewal at Davis-Besse, a FENOC
plant in Sandusky, OH, was awarded to the team. The team also is responsible for
license renewal at all Entergy plants and currently is preparing applications for the
Pilgrim plant in Plymouth, MA, and Arkansas Nuclear One unit 2, Russellville, AR.
"The Framatome/Entergy team is honored to be providing our expertise as the U.S.
nuclear power industry assures its long-term status as the nation's most
dependable source of electricity," said Ray Ganthner, Framatome ANP, Inc. Vice
President of Engineering and Licensing. "Obtaining license renewals for U.S. plants
certainly brings the future of nuclear power more into focus."
"With the Cook project, Framatome/Entergy becomes the largest provider of
license renewal services to the U.S. nuclear power industry," said Randy
Hutchinson, senior vice president, business development, for Entergy Nuclear in
Jackson, MS. "Nuclear owners are recognizing the breadth of experience this team
brings to a life extension project. It saves them time and money."
Eight nuclear power plants have submitted license renewals to the NRC.
Framatome ANP, Inc. supported six renewal applications. Three applications
supported by Framatome ANP, Inc. have been approved and another three are
pending.
Framatome ANP offers a full range of nuclear engineering and advanced
technologies for both PWR and BWR plants, world class testing and qualification
facilities, and advanced monitoring and digital instrumentation and control systems
to enhance safety, improve plant operations and extend service life.
Framatome ANP (Advanced Nuclear Power), an AREVA and Siemens company, is
the world's premier nuclear supplier. Framatome ANP's focus includes
comprehensive engineering, instrumentation and control, nuclear services, heavy
component manufacture, modernization, fuel assemblies for many reactor designs,
including those supplied by other vendors, and the development and construction
of nuclear power plants and research reactors.
Framatome ANP is headquartered in Paris with principal subsidiaries in the U.S.
and Germany. In the company, AREVA has a 66% shares and Siemens 34%.
Framatome ANP has a total workforce of approximately 13,000 worldwide and
posts annual revenues totaling about $2.3 billion.
The AREVA Group, which combines the forces of Cogema, Framatome ANP and
Framatome Connectors International, has sales exceeding $8.6 billion and more
than 50,000 employees. The AREVA Group is the world leader in nuclear power
and the second largest group worldwide in connectors. The total revenue from its
North American companies should now exceed $1.5 billion.
The nuclear businesses of Entergy are headquartered in Jackson, Miss. Entergy, a
global energy company based in New Orleans, is the third largest power generator
in the nation with more than 30,000 megawatts of generating capacity, about $10
billion in revenue and over 2.6 million customers. Entergy's nuclear businesses
encompass five power reactors at four locations in Arkansas, Mississippi and
Louisiana under regulatory jurisdictions, and four reactors at three sites in
Massachusetts and New York. Entergy Nuclear has also signed an agreement to
purchase the Vermont Yankee plant at Vernon, Vt., and expects to close that
transaction in 2002. Entergy Nuclear also furnishes license renewal and
decommissioning services to the U.S. nuclear power industry.
-----------------
Novoste Receives FDA Approval for Smaller Beta-Cath System Catheter
NORCROSS, Ga.--(BW HealthWire)--Feb. 13, 2002--
Beta-Cath(TM) 3.5F System offers the smallest diameter catheter
commercially available
Novoste Corporation (Nasdaq: NOVT) today announced that it has received U.S.
Food and Drug (FDA) approval to market its next generation smaller diameter
catheter system, the Beta-Cath(TM) 3.5 French (F) System, to treat in-stent
restenosis.
The Beta-Cath(TM) 3.5F System, offered with both a 30mm and 40mm radiation
source train, includes the smallest diameter vascular brachytherapy catheter
commercially available. The Beta-Cath(TM) 3.5F System can be used with a 6F
guide catheter and incorporates a proprietary "jacketed" small radiation source
train. The smaller catheter diameter and multiple radiation lengths should allow the
Beta-Cath(TM) 3.5F System to be particularly useful in the treatment of in-stent
restenosis. Due to its lower profile, the 3.5F System will be able to treat areas
unable to be addressed with the current 5F System.
Thomas D. Weldon, Chairman and CEO of Novoste Corporation, commented on
this milestone achievement, "The Beta-Cath(TM) 3.5F System has been used
clinically outside the U.S. where physician acceptance has been very positive due
to its lower profile and compatibility with commonly used 6F guide catheter
systems. The U.S. approval of the 3.5F System continues our effort of expanding
the Beta-Cath(TM) product line to build upon our global market leadership position
in vascular brachytherapy. At the end of 2001, the Beta-Cath(TM) System had
been installed in nearly 340 hospitals in the U.S."
About Novoste Corporation:
Novoste Corporation, based in Atlanta, GA, develops advanced medical treatments
for coronary and vascular diseases and is the worldwide leader in vascular
brachytherapy. The company's Beta-Cath(TM) System is commercially available in
the United States, as well as in the European Union and several other countries.
Novoste Corporation shares are traded on the NASDAQ National Stock Market
under the symbol NOVT. For general company information, please call (770) 717-
0904 or visit the company's web site at www.novoste.com.
------------------
SCT Awarded New Patent for CaF2 Technology
Patent No. 6,334,899 Granted for CaF2 Plate Crystal Growth Process Technology
And CaF2 Raw Material Purification Apparatus
GILBERT, Ariz., Feb. 14 /PRNewswire/ -- Single Crystal Technologies, LLC (SCT),
revolutionizing materials technology, today announced the award of another U.S.
Patent, further extending its intellectual property in next-generation materials
technology for the semiconductor manufacturing industry. Patent 6,334,899 for
Continuous Crystal Plate Growth Apparatus covers additional aspects of the SCT
process and apparatus for calcium fluoride (CaF2) purification and plate crystal
growth. Large volumes of extremely pure CaF2 crystals will be crucial to the next
phase of semiconductor photolithography. SCT filed for the patent in June of 1995.
The special emphasis of this patent is on the process and apparatus for CaF2 raw
material purification and the process and apparatus for crystal growth of CaF2
plates of superior quality and in high yields, for commercial 193-nanometer and
157-nanometer wavelength semiconductor lithography. The SCT processes lower
production costs and dramatically increase output yields of optical crystals such as
CaF2, which are essential to making faster, lower-power-consumption chips.
"This technology answers the industry's need for higher quality and quantity of
CaF2 lenses so that smaller and faster next-generation semiconductor integrated
circuits can be mass produced," stated Ken Schroeder, president and COO of
SCT. "The industry agrees that the material they need for stepper lenses is
calcium fluoride -- they just can't produce enough material of a high enough quality
to meet the need. That's where our crystal plate growth system really delivers."
At 157nm next-generation wavelengths, current optical materials such as fused
silica transmit light so poorly that they can no longer pattern circuits onto silicon
wafers for chips, so the industry is moving toward new materials such as CaF2 to
solve these problems. The new materials require extremely high purity and single-
crystal quality that are not currently available.
"At best, today's crystal growers can only achieve 157nm-suitable calcium fluoride
crystal yields of about 3%-5%, making it very expensive to produce significant
numbers of usable crystals," said Dr. Kiril A. Pandelisev, CEO and chief scientist of
SCT, whose research led to the development of the patented technology. "The
increased yields made possible by our patented process will enable semiconductor
makers to pack their designs into chips less than half the size of current mass-
produced chips and to produce new, higher level technology."
The new purification method described in the latest patent will result in very
efficient and controlled removal of undesired impurities, as well as controlled
addition of desired impurities used to better control the material's properties. For
example, removal of Erbium (Er) and Lutetium (Lu) from the CaF2 material, to
mention only two of the 14 rare earth elements, will eliminate fluorescence of
lenses under 157nm laser beam illumination. The result will be a sharper chip
pattern image projected on the wafer. Furthermore, elimination of impurities such
as Lead (Pb) makes CaF2 even more transparent to 157nm light, so lenses can be
clocked and stacked to compensate for the material's surface properties and
intrinsic birefringence, respectively. Controlled impurities in the material allow for
control of the material hardness and of its "non-intrinsic" (man-made or process-
induced) birefringence. Improved light transmission and material properties
uniformity also allow more uniform illumination and enable laser damage to be
reduced through the use of lower intensity lasers.
The new crystal plate growth approach can be extended to many materials beyond
CaF2 lens production. For example, it also provides a basis for growth of ternary
compounds such as CaxBa1-xF2, CaxSr1-xF2 (where 1 is less than/equal to x is
greater than/equal to 0) and other materials that are impossible to grow by the
Bridgman-Stockbarger method, mainly due to segregation and constitutional
supercooling.
About SCT
Single Crystal Technologies (SCT, LLC), headquartered in Gilbert, AZ, has
developed a groundbreaking method of purifying and growing single-crystal
materials through patent-protected materials technology, including enhanced
methods of purification that can potentially triple standard crystal production yields.
It also encompasses innovative methods of crystal growth that will revolutionize an
industry still dependent on methods first introduced in the 1920's. SCT has initially
focused on CaF2 material, though the results of this technology will later be
expanded to a range of other industries including military, aerospace, nuclear
medicine and specialized sensors material for energy explorations, airport security
scanners, among others. All SCT United States patents have been extended
internationally. More information is available at http://www.sct-llc.com
------------------------------------------------------------------------
Sandy Perle Tel:(714) 545-0100 / (800) 548-5100
Director, Technical Extension 2306
ICN Worldwide Dosimetry Service Fax:(714) 668-3149
ICN Pharmaceuticals, Inc. E-Mail: sandyfl@earthlink.net
ICN Plaza, 3300 Hyland Avenue E-Mail: sperle@icnpharm.com
Costa Mesa, CA 92626
Personal Website: http://sandy-travels.com
ICN Worldwide Dosimetry Website: http://www.dosimetry.com
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line. You can view the Radsafe archives at http://www.vanderbilt.edu/radsafe/